What is NDC 0574-1420?

0574-1420 is the product NDC for Lenalidomide, Lenalidomide 20 mg/1 capsule, listed with the FDA by Padagis US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Padagis US LLC, NDC labeler code 0574. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lenalidomide?

107 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lenalidomide NDC 0574-1420 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0574-1420Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00574-1420Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0574-1420-21	00574142021	21 CAPSULE in 1 BOTTLE (0574-1420-21)Marketed from Jan 31, 2026

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lenalidomide
Generic name (nonproprietary): lenalidomide
Active ingredients: Lenalidomide — 20 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Padagis US LLCNDC labeler code 0574
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217265
Marketing start: Jan 31, 2026
Listing expires: Dec 31, 2026
Identifiers: Product ID 0574-1420_dffe719b-4f61-47e2-b71c-673322d487f5SPL ID dffe719b-4f61-47e2-b71c-673322d487f5SPL set ID dffe719b-4f61-47e2-b71c-673322d487f5RxCUI 602910, 602912, 643712, 643720, 1242231, 1428947UNII F0P408N6V4
Pharmacologic class: Thalidomide Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400574142021 followed by a unit qualifier and the quantity

Package 00574-1420-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 25, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Lenalidomide capsules are a thalidomide analogue indicated for the treatment of adult patients with: • Multiple myeloma (MM), in combination with dexamethasone ( 1.1 ). • MM, as maintenance following autologous hematopoietic stem cell transplantation (auto-HSCT) ( 1.1 ). • Transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q abnormality with or without additional cytogenetic abnormalities ( 1.2 ). Limitations of Use: • Lenalidomide capsules are not indicated and are not recommended for the treatment of patients with chronic lymphocytic leukemia (CLL) outside of controlled clinical trials ( 1.6 ). 1.1 Multiple Myeloma Le…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0574-1420

What is NDC 0574-1420?: 0574-1420 is the product NDC for Lenalidomide, Lenalidomide 20 mg/1 capsule, listed with the FDA by Padagis US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lenalidomide.
What is the active ingredient?: Lenalidomide.
Who is the labeler?: Padagis US LLC, NDC labeler code 0574. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lenalidomide?: 107 other product NDCs are listed under this name. See all Lenalidomide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lenalidomide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lenalidomide	Lenalidomide 2.5 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-692	16729-0692-09
Lenalidomide	Lenalidomide 25 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-697	16729-0697-06
Lenalidomide	Lenalidomide 15 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-695	16729-0695-06
Lenalidomide	Lenalidomide 5 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-693	16729-0693-09
Lenalidomide	Lenalidomide 20 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-696	16729-0696-06
Lenalidomide	Lenalidomide 10 mg/1	CapsuleOral	Accord Healthcare Inc.	16729-694	16729-0694-09
Lenalidomide	Lenalidomide 2.5 mg/1	CapsuleOral	Devatis Inc.	73043-038	73043-0038-0173043-0038-28
Lenalidomide	Lenalidomide 5 mg/1	CapsuleOral	Devatis Inc.	73043-039	73043-0039-0173043-0039-28
Lenalidomide	Lenalidomide 10 mg/1	CapsuleOral	Devatis Inc.	73043-040	73043-0040-0173043-0040-28
Lenalidomide	Lenalidomide 15 mg/1	CapsuleOral	Devatis Inc.	73043-041	73043-0041-0173043-0041-21

All 108 Lenalidomide NDCs

Other NDCs under ANDA 217265

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217265
Product	Strength	Form · route	Labeler	Product NDC
Lenalidomide	Lenalidomide 2.5 mg/1	CapsuleOral	Padagis US LLC	0574-1402
Lenalidomide	Lenalidomide 5 mg/1	CapsuleOral	Padagis US LLC	0574-1405
Lenalidomide	Lenalidomide 10 mg/1	CapsuleOral	Padagis US LLC	0574-1410
Lenalidomide	Lenalidomide 15 mg/1	CapsuleOral	Padagis US LLC	0574-1415
Lenalidomide	Lenalidomide 25 mg/1	CapsuleOral	Padagis US LLC	0574-1425